Emergent BioSolutions EBS
NYSE EBS
$6.09 -0.01 (-0.16%)
As of: Nov 10, 2026 · 12:28 PM EST

Emergent BioSolutions (EBS) Notes Payables (2016 - 2024)

Updated

Analysis

Emergent BioSolutions (EBS) Notes Payables (2016 - 2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 Emergent BioSolutions 310.37 Mn -370.73 Mn 29.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2024 800,000.00
Jun 30, 2024 415.20 Mn
Mar 31, 2024 459.20 Mn
Dec 31, 2023 413.70 Mn
Sep 30, 2023 413.60 Mn
Jun 30, 2023 455.20 Mn
Mar 31, 2023 950.70 Mn
Dec 31, 2022 957.30 Mn
Sep 30, 2022 21.20 Mn
Jun 30, 2022 31.60 Mn
Mar 31, 2022 31.60 Mn
Dec 31, 2021 31.60 Mn
Sep 30, 2021 31.60 Mn
Jun 30, 2021 28.80 Mn
Mar 31, 2021 26.00 Mn
Dec 31, 2020 33.80 Mn
Sep 30, 2020 30.90 Mn
Jun 30, 2020 29.10 Mn
Mar 31, 2020 26.30 Mn
Dec 31, 2019 12.90 Mn
API Access

Emergent BioSolutions Notes Payables API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=notes-payables&ticker=EBS&period=max&api_key=YOUR_API_KEY